Company: CRVO
Filing Date: 2025-12-05
Form Type: 8-K
Source: 0001437749-25-037025
Chunk: 2

Company: CervoMed Inc.
Filing Date: 2025-12-05
Form: 8-K
Item: Item 8.01
Chunk 2
---

Item 8.01   Other Events
------------------------
 
The information set forth, (i) with respect to the December 2 Press Release, in the first two paragraphs and under the heading, “Treatment Benefit Associated with Biomarker Measurements,” and (ii) with respect to the December 4 Press Release, in the first paragraph and under the heading, “Results from the Phase 2b RewinD-LB Trial,” is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K.